Articles

31. Where Innovation Is Moving The Advanced Therapies Supply Chain 4/28/2026

    Assimilate how advanced therapy supply chains are evolving toward patient-centric, risk-managed, digitally connected models to support scale, reliability, and regulatory confidence globally today.

32. History Of Peptides In Medicine: From Early Chemistry To The GLP-1 Era 4/21/2026

    Peptide therapeutics from early chemical breakthroughs to today’s metabolic drugs, highlighting scientific, clinical, and manufacturing advances shaping modern drug development.

33. IP Considerations In Drug Development For Biotech Companies 4/20/2026

    Integrate a strategic intellectual property approach early in drug development to streamline research, uncover opportunities, and maximize the return on your investment.

34. Unlock The Power Of mRNA With Analytical Testing 4/16/2026

    Ensure your mRNA therapeutics meet evolving regulatory expectations by leveraging advanced analytical testing for characterization, stability, and product release aligned with the latest USP standards.

35. Beyond Particle Counting: Why Modern Biologics Need Particle Forensics 4/8/2026

    High particle counts don’t always mean high risk. Identifying particle type and origin—not just quantity—avoids false alarms, protects timelines, and turns data into action.

36. From Discovery To Delivery: A Smarter Path For Scaling Biologics 4/8/2026

    A unified global model streamlines biologics from discovery to commercial supply, integrating development, manufacturing, advanced modalities, and flexible partnerships worldwide.

37. Flexibility In Drug Development: From Tactical Response To Strategic Imperative 4/6/2026

    Build flexibility into your drug development strategy to navigate change effectively, maintain momentum, and drive successful outcomes across every stage of the lifecycle.

38. Early-Phase Injectable Formulation Development 4/6/2026

    Discover how expert-driven strategies and data-centric tools can help you overcome formulation challenges and accelerate the development of stable, high-performance injectable therapeutics.

39. Product Development Services (PDS) For Steriles 4/6/2026

    Our capabilities include formulation development, compounding, lyophilization, analytical testing, and fill-finish operations.

40. Systematic Strategy To Reduce The Cost Of Goods Sold 3/26/2026

    Learn key ways to cut biologics manufacturing costs through smarter process design, material choices, and supply resilience — driving more efficient, reliable, and commercially sustainable production.